Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Zoledronic Acid × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 39 Breast 38 Plasma cell 17 Thoracic 7 Sarcoma 5 Lymphoid 3 CNS 3 Other hematologic neoplasm 2 Gynecologic 2 Gastrointestinal 2 Tumor-Agnostic 1 Other solid neoplasm 1 Myeloid 1 Head & Neck 1

Conditions

Interventions

Cisplatin 70 Carboplatin 49 Gemcitabine 48 Paclitaxel 46 Irinotecan 46 Pemetrexed 37 Docetaxel 31 Nivolumab 26 Fluorouracil 25 Capecitabine 22 Bevacizumab 22 Cyclophosphamide 21 Oxaliplatin 19 Topotecan 17 Leucovorin 17 Sorafenib 16 Erlotinib Hydrochloride 16 pembrolizumab 15 Etoposide 15 Bortezomib 15 Ipilimumab 14 Everolimus 14 durvalumab 13 Sirolimus 13 Sunitinib 12 Injections 12 Filgrastim 12 Early Intervention, Educational 12 alvocidib 11 Temozolomide 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204203 2017-05-24

UAB0901

University of Alabama at Birmingham

Phase 2 Completed

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡